Dr. Reda Ibrahim, MD
Claim this profileInstitut de Cardiologie de Montreal (Montreal Heart Inst.)
Studies Stroke
Studies Von Willebrand Disease
9 reported clinical trials
18 drugs studied
Affiliated Hospitals
Clinical Trials Reda Ibrahim, MD is currently running
WATCHMAN Device
for Atrial Fibrillation
LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.
Recruiting1 award N/A3 criteria
Left Atrial Appendage Occlusion vs. NOAC
for Atrial Fibrillation
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Recruiting1 award N/A8 criteria
More about Reda Ibrahim, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Reda Ibrahim, MD has experience with
- ACURATE Neo2™ Transfemoral TAVR System
- Medtronic CoreValve TAVR System
- Edwards SAPIEN 3 TAVR System
- ACURATE Prime™ Transfemoral TAVR System XL
- Occlutech Figulla Flex II®
- AMPLATZER™ Septal Occluder
Breakdown of trials Reda Ibrahim, MD has run
Stroke
Von Willebrand Disease
Patent Foramen Ovale
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reda Ibrahim, MD specialize in?
Reda Ibrahim, MD focuses on Stroke and Von Willebrand Disease. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Reda Ibrahim, MD currently recruiting for clinical trials?
Yes, Reda Ibrahim, MD is currently recruiting for 3 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Reda Ibrahim, MD has studied deeply?
Yes, Reda Ibrahim, MD has studied treatments such as ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System.
What is the best way to schedule an appointment with Reda Ibrahim, MD?
Apply for one of the trials that Reda Ibrahim, MD is conducting.
What is the office address of Reda Ibrahim, MD?
The office of Reda Ibrahim, MD is located at: Institut de Cardiologie de Montreal (Montreal Heart Inst.), Montréal, Quebec H1T 1C8 Canada. This is the address for their practice at the Institut de Cardiologie de Montreal (Montreal Heart Inst.).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.